We are live on ! Find out more
NBTX

Nanobiotix
NBTX

9 hedge funds and large institutions have $46.5M invested in Nanobiotix in 2021 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.18% less ownership

Funds ownership: 13.94% → 11.76% (-2.2%)

10% less funds holding

Funds holding: 10 → 9 (-1)

31% less capital invested

Capital invested by funds: $66.9M → $46.5M (-$20.4M)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
9
Holders Change
-1
Holders Change %
-10%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$7.51K

Top Sellers

Rank Fund Capital Flow
1
TCM
Tybourne Capital Management
Hong Kong
-$10.3M
2
WP
Woodline Partners
California
-$112K
3
Millennium Management
Millennium Management
New York
-$6.62K

NBTX Hedge Fund Activity: Q3 2021 in Review

9 of the 5,729 institutional investors tracked by Wall St. Rank reported a position in Nanobiotix (NBTX) for Q3 2021, worth a combined $46.5M — down 31% from $66.9M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of NBTX and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.

The largest buyer was UBS Group, adding an estimated $7.51K. The largest seller was Tybourne Capital Management, exiting entirely with an estimated $10.3M sold.

  • 9 institutional investors held Nanobiotix (NBTX) as of Q3 2021, down from 10 in Q2 2021.
  • Funds reported $46.5M of Nanobiotix stock for Q3 2021, down 31% quarter-over-quarter.
  • 0 funds opened new Nanobiotix positions in Q3 2021 and 1 closed out, a net change of -1 holder.
  • The largest Nanobiotix buyer in Q3 2021 was UBS Group, an estimated $7.51K added.
  • The largest Nanobiotix seller in Q3 2021 was Tybourne Capital Management, an estimated $10.3M sold.

Based on aggregated 13F filings for Q3 2021.